Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Senolytics to Improve Physical and Cognitive Function in Older Adults With Multiple Sclerosis

NCT07270120 is registered in ClinicalTrials.gov with Ohio State University as lead sponsor.

NCT NCT07270120
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07270120 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Senolytics to Improve Physical and Cognitive Function in Older Adults With Multiple Sclerosis
Lead sponsor
Ohio State University
Phase
Phase 1
Overall status
Not yet recruiting
Start date
January 15, 2026
Completion date
January 15, 2028
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis (ms) secondary progressive